WINTON GROUP Ltd Sells 21,015 Shares of Calumet, Inc. $CLMT

WINTON GROUP Ltd cut its holdings in Calumet, Inc. (NASDAQ:CLMT) by 31.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 45,085 shares of the oil and gas company’s stock after selling 21,015 shares during the quarter. WINTON GROUP Ltd owned about 0.05% of Calumet worth $896,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CLMT. Mariner LLC boosted its stake in Calumet by 959.6% in the third quarter. Mariner LLC now owns 369,408 shares of the oil and gas company’s stock valued at $6,742,000 after acquiring an additional 334,544 shares during the last quarter. Marshall Wace LLP raised its holdings in Calumet by 35.8% in the third quarter. Marshall Wace LLP now owns 891,390 shares of the oil and gas company’s stock worth $16,268,000 after purchasing an additional 234,766 shares during the period. Goldman Sachs Group Inc. raised its holdings in Calumet by 128.3% in the fourth quarter. Goldman Sachs Group Inc. now owns 348,115 shares of the oil and gas company’s stock worth $6,917,000 after purchasing an additional 195,627 shares during the period. BNP Paribas Financial Markets raised its holdings in Calumet by 18,512.3% in the second quarter. BNP Paribas Financial Markets now owns 183,890 shares of the oil and gas company’s stock worth $2,897,000 after purchasing an additional 182,902 shares during the period. Finally, UBS Group AG raised its holdings in Calumet by 90.0% in the fourth quarter. UBS Group AG now owns 358,628 shares of the oil and gas company’s stock worth $7,126,000 after purchasing an additional 169,900 shares during the period. 34.41% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have weighed in on CLMT. TD Cowen reiterated a “hold” rating on shares of Calumet in a report on Wednesday, June 3rd. Weiss Ratings upgraded shares of Calumet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. The Goldman Sachs Group lowered shares of Calumet from a “buy” rating to a “neutral” rating and set a $36.00 target price on the stock. in a report on Friday, April 24th. UBS Group reiterated a “neutral” rating and issued a $26.00 target price on shares of Calumet in a report on Friday, February 13th. Finally, HC Wainwright increased their target price on shares of Calumet from $33.00 to $60.00 and gave the stock a “buy” rating in a report on Monday, March 30th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $36.75.

Insiders Place Their Bets

In related news, Director Daniel J. Sajkowski sold 3,310 shares of the firm’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $34.46, for a total transaction of $114,062.60. Following the sale, the director directly owned 81,958 shares in the company, valued at $2,824,272.68. This trade represents a 3.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, major shareholder Group Heritage sold 626,998 shares of the firm’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $32.54, for a total transaction of $20,402,514.92. Following the sale, the insider owned 12,980,211 shares in the company, valued at approximately $422,376,065.94. The trade was a 4.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 4.07% of the company’s stock.

Calumet Stock Down 4.1%

Shares of NASDAQ:CLMT opened at $34.05 on Wednesday. Calumet, Inc. has a 12 month low of $12.94 and a 12 month high of $38.75. The company’s fifty day simple moving average is $33.61 and its 200 day simple moving average is $27.07. The firm has a market cap of $2.97 billion, a price-to-earnings ratio of -15.76 and a beta of 0.73.

Calumet (NASDAQ:CLMT) last issued its quarterly earnings data on Friday, May 8th. The oil and gas company reported ($3.64) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($3.31). The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1 billion. During the same quarter last year, the firm posted ($1.87) EPS. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. Research analysts expect that Calumet, Inc. will post -0.31 earnings per share for the current fiscal year.

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.